National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Incobotulinum Toxin Type A (Xeomin®)

Incobotulinum Toxin Type A (Xeomin®) is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults.

Rapid Review

Commenced Completed Outcome
07/02/2014 05/03/2014 Full Pharmacoeconomic Evaluation not recommended